These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27335115)

  • 1. Huntington disease reduced penetrance alleles occur at high frequency in the general population.
    Kay C; Collins JA; Miedzybrodzka Z; Madore SJ; Gordon ES; Gerry N; Davidson M; Slama RA; Hayden MR
    Neurology; 2016 Jul; 87(3):282-8. PubMed ID: 27335115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).
    Hendricks AE; Latourelle JC; Lunetta KL; Cupples LA; Wheeler V; MacDonald ME; Gusella JF; Myers RH
    Am J Med Genet A; 2009 Jul; 149A(7):1375-81. PubMed ID: 19507258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population.
    Semaka A; Kay C; Doty CN; Collins JA; Tam N; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):864-71. PubMed ID: 24038799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
    Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
    Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HTT CAG repeat expansion among healthy individuals and patients with chorea in Korea.
    Kim R; Seong MW; Oh B; Shin HS; Lee JS; Park S; Jang M; Jeon B; Kim HJ; Lee JY
    Parkinsonism Relat Disord; 2024 Jan; 118():105930. PubMed ID: 37992538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Huntington disease.
    Kay C; Hayden MR; Leavitt BR
    Handb Clin Neurol; 2017; 144():31-46. PubMed ID: 28947124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
    Wright GEB; Collins JA; Kay C; McDonald C; Dolzhenko E; Xia Q; Bečanović K; Drögemöller BI; Semaka A; Nguyen CM; Trost B; Richards F; Bijlsma EK; Squitieri F; Ross CJD; Scherer SW; Eberle MA; Yuen RKC; Hayden MR
    Am J Hum Genet; 2019 Jun; 104(6):1116-1126. PubMed ID: 31104771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Huntington disease in a northeastern Spanish region: a 13-year retrospective study at tertiary care centre.
    Sienes Bailo P; Lahoz R; Sánchez Marín JP; Izquierdo Álvarez S
    BMC Med Genet; 2020 Nov; 21(1):233. PubMed ID: 33228555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk.
    Fisher ER; Hayden MR
    Mov Disord; 2014 Jan; 29(1):105-14. PubMed ID: 24151181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset Huntington disease with intermediate CAG repeats: true or false?
    Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia.
    Almqvist EW; Elterman DS; MacLeod PM; Hayden MR
    Clin Genet; 2001 Sep; 60(3):198-205. PubMed ID: 11595021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis and prevalence of Huntington disease in northwestern Iran.
    Shekari Khaniani M; Aob P; Ranjouri M; Mansoori Derakhsan S
    Turk J Med Sci; 2017 Dec; 47(6):1880-1884. PubMed ID: 29306253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease.
    Semaka A; Kay C; Doty C; Collins JA; Bijlsma EK; Richards F; Goldberg YP; Hayden MR
    J Med Genet; 2013 Oct; 50(10):696-703. PubMed ID: 23896435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mutation for Huntington disease following maternal transmission of an intermediate allele.
    Semaka A; Kay C; Belfroid RD; Bijlsma EK; Losekoot M; van Langen IM; van Maarle MC; Oosterloo M; Hayden MR; van Belzen MJ
    Eur J Med Genet; 2015 Jan; 58(1):28-30. PubMed ID: 25464109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
    Kay C; Collins JA; Wright GEB; Baine F; Miedzybrodzka Z; Aminkeng F; Semaka AJ; McDonald C; Davidson M; Madore SJ; Gordon ES; Gerry NP; Cornejo-Olivas M; Squitieri F; Tishkoff S; Greenberg JL; Krause A; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):346-357. PubMed ID: 29460498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling.
    Nahhas F; Garbern J; Feely S; Feldman GL
    Am J Med Genet A; 2009 Feb; 149A(4):732-6. PubMed ID: 19267413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.
    ; Dorsey E
    PLoS One; 2012; 7(2):e29522. PubMed ID: 22359536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India.
    Pramanik S; Basu P; Gangopadhaya PK; Sinha KK; Jha DK; Sinha S; Das SK; Maity BK; Mukherjee SC; Roychoudhuri S; Majumder PP; Bhattacharyya NP
    Eur J Hum Genet; 2000 Sep; 8(9):678-82. PubMed ID: 10980573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implications.
    Brocklebank D; Gayán J; Andresen JM; Roberts SA; Young AB; Snodgrass SR; Penney JB; Ramos-Arroyo MA; Cha JJ; Rosas HD; Hersch SM; Feigin A; Cherny SS; Wexler NS; Housman DE; Cardon LR;
    Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):425-9. PubMed ID: 18712713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.